Therapeutic possibility of "Semax" for depression.
Pae
Chi-Un
CU
D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000818:Animals; D000928:Antidepressive Agents / Q000627:therapeutic use*; D019208:Brain-Derived Neurotrophic Factor / Q000378:metabolism; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D004298:Dopamine / Q000378:metabolism; D006624:Hippocampus / Q000187:drug effects; D051379:Mice; D010446:Peptide Fragments / Q000627:therapeutic use*; D012701:Serotonin / Q000378:metabolism
D000928:Antidepressive Agents; D019208:Brain-Derived Neurotrophic Factor; D000697:Central Nervous System Stimulants; D010446:Peptide Fragments; D012701:Serotonin; C048487:ACTH (4-7), Pro-Gly-Pro-; D000324:Adrenocorticotropic Hormone; D004298:Dopamine